摘要
目的:了解老年吸入性肺炎的临床治疗及预后情况。方法:老年吸入性肺炎患者125例,分析病原菌特点;总结抗生素治疗现况、治疗费用及预后。结果:分析125例患者发现,老年吸入性肺炎病原菌以革兰阴性杆菌为主,占57%,且耐药率高(58.3%),多数患者为混合感染;91例(73%)患者曾使用2种或2种以上的抗生素,抗生素治疗时间一般超过2周;平均住院时间为28 d,平均住院费用为2.5万元,抗生素花费平均为1.2万元,均明显高于普通肺炎;影响预后的主要因素包括年龄、基础疾病及器官衰竭。结论:老年吸入性肺炎重症患者多,治疗费用大,预后差。
Objective： To investigate the clinical treatment and prognosis of elderly patients with aspiration pneumonia（AP）.Methods： A total of 125 elderly patients with AP were enrolled.The aetiology,application of antibiotics,prognosis and cost of treatment were analyzed.Results： The main pathogens were Gram-negative bacilli（57%） with high drug-resistant rate（58.3%）,and most patients were mix-infected;91（73%） cases used 2 or more kinds of antibiotics,the duration of antibacterial therapy was more than 2 weeks in most cases;the average duration of hospitalization was 28 days while the average cost of hospitalization was 25 000 RMB;and the mean expenses of antibiotics for AP were were higher than that for common pneumonia.The related factors to the prognosis included age,basic diseases,and organ failures.Conclusion： The clinical features of elderly patients with AP were severe and not typical.Due to high cost and mortality rate,integrative therapy should be used.
出处
《武汉大学学报（医学版）》
CAS
北大核心
2010年第4期544-547,共4页
Medical Journal of Wuhan University
关键词
吸入性肺炎
老年
治疗
预后
Aspiration Pneumonia
Elderly
Treatment
Prognosis
